Lili Cheng

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Sir Run Run Shaw Hospital, Quantitative BioSciences, China Academy of Information and Communications Technology, Beijing Tsinghua Chang Gung Hospital, University of Chinese Academy of Sciences, Institute of Zoology, Tsinghua University · ORCID：0000-0001-8009-1069

发表论文 114 篇 · 总被引 4423 次 · h-index 35

代表论文

• An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19 (2021 · Signal Transduction and Targeted Therapy · 被引 206)
• SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility (2021 · Cell Reports · 被引 103)
• Hepatic mitochondrial NAD+ transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis (2023 · Hepatology · 被引 71)
• Structural insights into human organic cation transporter 1 transport and inhibition (2024 · Cell Discovery · 被引 35)
• MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation (2024 · Nature Communications · 被引 32)
• Ablation of Proton/Glucose Exporter SLC45A2 Enhances Melanosomal Glycolysis to Inhibit Melanin Biosynthesis and Promote Melanoma Metastasis (2022 · Journal of Investigative Dermatology · 被引 24)